New report highlights significant growth of global healthcare cloud computing market
A new report by Frost & Sullivan has highlighted the significant growth of the global healthcare cloud computing market, which will be worth $10bn by 2021. The traditional industry is undergoing a digital revolution in the face of ageing populations and rising costs, all of which are placing a strain on present services. This is in addition to added complexities and demands surrounding patient care and demands for high quality, patient patent centered healthcare.
The implementation of new technologies, such as the cloud will enable increased data security and provide the ability for healthcare providers to house confidential data whilst guaranteeing increased efficiencies within the healthcare sector.
Frost & Sullivan’s research therefore focuses on areas of potential growth, current and future business models, foreseen challenges, as well as essential solutions through the implementation of cloud technologies.
“One major industry game-changer will be real-world data. The volume of unstructured medical and health data that is generated outside of clinical settings is growing exponentially, while the need for such data sets is even direr among providers, pharmaceuticals, medical technology vendors, governments, and university researchers,” explained Digital Health Research Manager Natasha Gulati.
- Fullerton Healthcare receives $121mn in funding from Ping An Capital
- Facebook furthers its suicide prevention efforts with AI
- Google wants overhaul traditional GP documentation with voice recognition
“Growing awareness of the benefits of open platforms and increasing industry focus on interoperability and collaborative solution design are creating a huge demand for vertically integrated cloud platforms that open the data to multiple stakeholders who are willing to share the risks and the rewards of shared data assets.”
Acute healthcare facilities, such has hospitals and GP practices will also utilise cloud technology and applications to manage, store and archive vast volumes of data and patient information, as well as centralise information from a number of healthcare providers into one core platform.
“In the past few years there have been significant investments in internal apps that integrate with EHRs, with the United States taking the lead in this area,” added Gulati. “Platform as a Service (PaaS) offers greater control over custom apps developed by providers compared to Software as a Service (SaaS), while it reduces the costs as well as data location and ownership concerns associated with Infrastructure as a Service (IaaS).
Increasing demand for mobile apps, from both clinical staff and patients further fuels the need for custom app development.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”